Literature DB >> 35013861

Bioactive components to inhibit foam cell formation in atherosclerosis.

Sanjiv Singh1, Senti Changkija2, Rajat Mudgal2, V Ravichandiran2.   

Abstract

BACKGROUND: The production of lipid-laden cells in macrophages after significant ingestion of oxidized low-density lipoprotein is considered the most critical phase in the creation of atherosclerotic lesions, which is known as foam cell formation. Targeting foam cell development to find a potential therapeutic strategy for the management of atherosclerosis has yielded numerous promising outcomes. Multiple variables influence foam cell growth, including scavenger receptor expression, cholesterol transporter expression acyl CoA: cholesterol acyltransferase activity, and neutral cholesteryl ester hydrolase activity. Plants used during herbal therapy have been shown to assist with a variety of ailments. RESULT: In this study, we found medicinal plants and their bioactive components suppress foam cell formation in a variety of ways; some inhibit cholesterol transporter and lectin-like oxidized low-density lipoprotein receptor-1 upregulation, while others inhibit the function of acyl CoA: cholesterol acyltransferase activity, and neutral cholesteryl ester hydrolase activity.
CONCLUSION: Recent study findings related to the synthesis of the new active component from plant sources by focusing on the typical process involved in the generation of foam cells. We're also looking at using a cellular target-based therapeutic approach to generate novel plant-based medications for the cure of atherosclerosis.
© 2021. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  Atherosclerosis; Bioactive components; Endothelial dysfunction; Foam cell formation; Herbal medicine; Macrophages

Mesh:

Substances:

Year:  2022        PMID: 35013861     DOI: 10.1007/s11033-021-07039-9

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  62 in total

1.  Periodontal disease and atherosclerotic vascular disease: does the evidence support an independent association?: a scientific statement from the American Heart Association.

Authors:  Peter B Lockhart; Ann F Bolger; Panos N Papapanou; Olusegun Osinbowale; Maurizio Trevisan; Matthew E Levison; Kathryn A Taubert; Jane W Newburger; Heather L Gornik; Michael H Gewitz; Walter R Wilson; Sidney C Smith; Larry M Baddour
Journal:  Circulation       Date:  2012-04-18       Impact factor: 29.690

Review 2.  Inflammation in atherosclerosis.

Authors:  Peter Libby
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-09       Impact factor: 8.311

Review 3.  Plaque angiogenesis and its relation to inflammation and atherosclerotic plaque destabilization.

Authors:  Margreet R de Vries; Paul H A Quax
Journal:  Curr Opin Lipidol       Date:  2016-10       Impact factor: 4.776

Review 4.  Endothelial Cell Dysfunction and the Pathobiology of Atherosclerosis.

Authors:  Michael A Gimbrone; Guillermo García-Cardeña
Journal:  Circ Res       Date:  2016-02-19       Impact factor: 17.367

Review 5.  Monocyte-Macrophages and T Cells in Atherosclerosis.

Authors:  Ira Tabas; Andrew H Lichtman
Journal:  Immunity       Date:  2017-10-17       Impact factor: 31.745

Review 6.  Herbal Approach for Management of Atherosclerosis: a Review.

Authors:  Sanjiv Singh
Journal:  Curr Atheroscler Rep       Date:  2019-02-28       Impact factor: 5.113

Review 7.  Circulating markers of inflammation and atherosclerosis.

Authors:  Lars Lind
Journal:  Atherosclerosis       Date:  2003-08       Impact factor: 5.162

Review 8.  Physiology and pathophysiology of oxLDL uptake by vascular wall cells in atherosclerosis.

Authors:  Natalia Di Pietro; Gloria Formoso; Assunta Pandolfi
Journal:  Vascul Pharmacol       Date:  2016-05-30       Impact factor: 5.773

Review 9.  Endothelial and smooth muscle cell transformation in atherosclerosis.

Authors:  Ka Hou Lao; Lingfang Zeng; Qingbo Xu
Journal:  Curr Opin Lipidol       Date:  2015-10       Impact factor: 4.776

Review 10.  Endothelial Barrier and Its Abnormalities in Cardiovascular Disease.

Authors:  Dimitry A Chistiakov; Alexander N Orekhov; Yuri V Bobryshev
Journal:  Front Physiol       Date:  2015-12-09       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.